CompletedNCT07101120
Official study titleA Phase 2, Two-Part (Open-Label Followed by Double-Blind) Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Efficacy of KH607 in the Treatment of Adult Participants With Moderate or Severe Major Depressive Disorder
This study has finished and is no longer accepting participants.
In BeijingDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
CompletedNCT06842992
What is this study about?This study evaluated the safety and effectiveness of NH102 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including HefeiDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Jiangsu Nhwa Pharmaceutical Co., Ltd.
UnknownNCT03642964
Official study titleA Phase 2a Study to Evaluate the Safety, Tolerability and Initial Efficacy of Pramipexole IR, Given With Ondansetron in Patients With Major Depressive Disorder
Current recruitment status is unconfirmed.
In Long BeachDepressionMedication studyAges 18–65
- Countries
- United States
- Sponsor
- Chase Therapeutics Corporation
CompletedNCT06792136
What is this study about?This study evaluated the safety and effectiveness of ONO-1110 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including FukuokaDepressionMedication studyAges 18–65
- Countries
- Japan
- Sponsor
- Ono Pharmaceutical Co., Ltd.
TerminatedNCT06618118
Official study titleA Phase 1 b Randomized, Double-blind, Placebo-Controlled, Experimental Medicine Study of Fosigotifator in Adults With Major Depressive Disorder
This study ended early.
Multiple locations, including Sherman OaksDepressionMedication studyAges 20–70
- Countries
- United States
- Sponsor
- AbbVie
CompletedNCT06796868
Official study titleA Multicenter, Randomized , Double-blind, Parallel, Placebo-controlled Design Clinical Trial of GW117 Tablets
This study has finished and is no longer accepting participants.
Multiple locations, including BaodingDepressionMedication studyAges 18–65
- Countries
- China
- Sponsor
- Beijing Greatway Pharmaceutical Technology Co.,Ltd.
CompletedNCT07193901
Official study titleA Randomized, Double-blind, Placebo-controlled Phase Il Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior
This study has finished and is no longer accepting participants.
Multiple locations, including BeijinDepression, SuicidalityMedication studyAges 18–64
- Countries
- China
- Sponsor
- Sichuan Purity Pharmaceutical Technology Co., Ltd.
CompletedNCT01701258
Official study titleEarly Life Stress and Depression: Molecular and Functional Imaging Approaches
This study has finished and is no longer accepting participants.
Multiple locations, including BelmontDepressionMedication studyAges 20–45
- Countries
- United States
- Sponsor
- Mclean Hospital (Hospital / academic medical center)
Active Not RecruitingNCT05008198
Official study titleAssessing an Electroencephalography (EEG) Biomarker of Response to Transcranial Magnetic Stimulation for Major Depression
This study is no longer accepting new participants.
In White River JunctionDepressionObservational studyAges 18+
- Countries
- United States
- Sponsor
- VA Office of Research and Development (Government agency)
CompletedNCT06661616
Official study titleCognitive Effects Associated With Hippocampal Neurogenesis Induced by Electroconvulsive Therapy in the Treatment of Depression
This study has finished and is no longer accepting participants.
In ParisDepression, BipolarityObservational studyAges 18+
- Countries
- France
- Sponsor
- Centre Hospitalier St Anne
CompletedNCT04832750
This study has finished and is no longer accepting participants.
In Bad ZwischenahnPersonality disorders, DepressionObservational studyAges 18–65
- Countries
- Germany
- Sponsor
- University of Oldenburg
CompletedNCT04598906
Official study titleComparison of the Effectiveness of the Virtual Environment in Cognitive Rehabilitation With Standard Rehabilitation Methods in Patients With Schizophrenia and in Patients With Major Depressive Disorder
This study has finished and is no longer accepting participants.
In FryštátDepression, SchizophreniaBehavioural studyAges 18–60
- Countries
- Czechia
- Sponsor
- National Institute of Mental Health, Czech Republic